TNF and inflammatory bowel disease: The booster vaccination significantly improved antibody responses across all groups, but IBD patients on anti-TNF therapy continued to show significantly lower median anti-spike antibody levels and neutralization activities compared to HCW, with still 15% of them being non-neutralizers.